Quidel's C. difficile test gets FDA OK for Life's Dx platforms

03/19/2013 | GenomeWeb Daily News (free registration)

Quidel has received FDA clearance for its Molecular Direct C. difficile Assay to be used with the 7500 Fast Dx Applied Biosystems Real-Time PCR Instrument and QuantStudio Dx from Life Technologies. The test kit uses a three-step, extraction-free specimen preparation process and takes under 70 minutes to generate results, the companies said.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Associate Manager, Regulatory Affairs
Mahwah, NJ
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC